Back to search
FDAFDA · Food and drugs·Recall number D-0798-2021

Candesartan Cilexetil Tablets, USP 16 mg, 30 count bottles, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 NDC 0378-3231-93

Published September 22, 2021 · Recall initiated: September 13, 2021

Summary

FDA records drug Class III recall D-0798-2021, published September 22, 2021 and initiated September 13, 2021. Recalling firm: Viatris; Status: Terminated; Reported quantity: 21,094; Lot: Lot # 3107334, exp. date October 2021. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications; out of specification for Related Compound

What to do

Voluntary: Firm initiated · Letter

Get an email if CANDESARTAN CILEXETIL has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
CANDESARTAN CILEXETIL
Manufacturer
Viatris
Distributor
Product was distributed nationwide.
UPC
0303783232935
Lot
Lot # 3107334, exp. date October 2021
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Candesartan Cilexetil Tablets, USP 16 mg, 30 count bottles, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 NDC 0378-3231-93 recalled?

Yes. FDA published recall D-0798-2021 on September 22, 2021. Reported hazard: Failed Impurities/Degradation Specifications; out of specification for Related Compound

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: CANDESARTAN CILEXETIL. UPC: 0303783232935.